Greenland Mines Prices $17.2M Direct Offering at $13.00 — 11% Below Last Sale
GRML has more than doubled off its 52-week low of $2.82.
Summary
Greenland Mines priced a 1.32 million share direct offering at $13.00 per share, raising ~$17.2 million — its second raise in five days amid going-concern doubts and a Nasdaq delisting deadline.
Updates
· GlobeNewswire — Greenland Mines raised over $17 million at $13.00 per share, bringing total capital raised over the past week to over $59 million.
Key Events · Financing and Capital Events · GRML
-
Direct Offering Priced at $13.00
1,320,000 shares offered at $13.00 per share, raising approximately $17.2 million in net proceeds. No placement agent was retained — the price was negotiated directly with investors.
-
Priced 11% Below Last Sale
The $13.00 offering price is 11% below the $14.66 last reported sale price on September 25, 2026, reflecting the company's urgent capital needs.
-
Second Raise in Five Days
This follows the $38.4 million direct offering priced at $12.00 on September 23, 2026 — nearly $55 million in combined gross proceeds within one week.
-
ATM Program Terminated
The $50 million ATM Sales Agreement with A.G.P. was terminated after only $1,388,827.04 in shares were sold under the program.
Analysis · GRML · Life Sciences
Greenland Mines is selling 1.32 million shares at $13.00 each, raising about $17.2 million. The price is 11% below the $14.66 last reported sale on September 25, 2026 — a modest discount that reflects the company's urgent need for capital. This is the second direct offering in five days, following the $38.4 million raise at $12.00 on September 23, bringing combined gross proceeds to roughly $55 million within one week. The company faces going-concern doubts and a Nasdaq delisting deadline, so this capital is critical for survival, but the rapid-fire dilution is a real cost to existing shareholders. The offering also terminates the underperforming $50M ATM program that had sold only $1.4 million.
How filings like this one have moved
In the 30 days to Oct 16, 2026, 29.5% of the 1476 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.41%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, GRML was trading at $11.68 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $104.6M. The 52-week trading range was $2.82 to $36.99. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.